Melatonin as a Potential Agent in the Treatment of Sarcopenia
about
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Melatonin therapy for blunt trauma and strenuous exercise: A mechanism involving cytokines, NFκB, Akt, MAFBX and MURF-1.Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.Effects of dietary supplementation with milk fat globule membrane on the physical performance of community-dwelling Japanese adults: a randomised, double-blind, placebo-controlled trial.
P2860
Melatonin as a Potential Agent in the Treatment of Sarcopenia
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@ast
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@en
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@nl
type
label
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@ast
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@en
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@nl
prefLabel
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@ast
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@en
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@nl
P2860
P921
P3181
P356
P1476
Melatonin as a Potential Agent in the Treatment of Sarcopenia
@en
P2093
Russel J Reiter
P2860
P3181
P356
10.3390/IJMS17101771
P407
P577
2016-10-24T00:00:00Z